HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B

被引：0

作者：

Sonneveld, Milan J. ^{[1
]}

Rijckborst, Vincent ^{[1
]}

Zoutendijk, Roeland ^{[1
]}

Gerken, Guido ^{[2
]}

Tabak, Fehmi ^{[3
]}

Mach, Tomasz H. ^{[4
]}

Boucher, Charles A. ^{[1
]}

Hansen, Bettina E. ^{[1
]}

Janssen, Harry L. ^{[1
]}

机构：

[1] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands

[2] Univ Essen Gesamthsch, Essen, Germany

[3] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey

[4] Coll Med UJ, Krakow, Poland

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1030A / 1030A

页数：1

共 50 条

[1] PEGINTERFERON ALFA-2B INDUCED HBSAG DECLINE IS DURABLE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS
Sonneveld, Milan J.
Rijckborst, Vincent
Cakaloglu, Yilmaz
Simon, Krzysztof
Trojan, Jorg
Tabak, Fehmi
Mach, Tomasz H.
Boucher, Charles A.
Hansen, Bettina E.
Janssen, Harry L.
HEPATOLOGY, 2010, 52 (04) : 518A - 519A
[2] Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Buster, Erik H. C. J.
Flink, Hajo J.
Cakaloglu, Yilmaz
Simon, Krzysztof
Trojan, Joerg
Tabak, Fehmi
So, Thomas M. K.
Feinman, S. Victor
Mach, Tomasz
Akarca, Ulus S.
Schutten, Martin
Tielemans, Wanda
van Vuuren, Anneke J.
Hansen, Bettina E.
Janssen, Harry L. A.
GASTROENTEROLOGY, 2008, 135 (02) : 459 - 467
[3] SERUM HBSAG LEVELS DECREASE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-NEGATIVE PATIENTS ACHIEVING A SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A
Rijckborst, Vincent
Hansen, Bettina E.
Pinarbasi, Binnur
Akdogan, Meral
ter Borg, Martijn J.
Ferenci, Peter
Simon, Krzysztof
Flisiak, Robert
Akarca, Ulus S.
Raptopoulou-Gigi, Maria
Verhey, Elke
van Vuuren, Anneke J.
Boucher, Charles A.
Janssen, Harry L.
HEPATOLOGY, 2010, 52 (04) : 561A - 562A
[4] Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
Niederau, C
Heintges, T
Lange, S
Goldmann, G
Niederau, CM
Mohr, L
Haussinger, D
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22): : 1422 - 1427
[5] Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China
Sun, Jian
Ding, Huiguo
Chen, Guofeng
Wang, Guiqiang
Wei, Lai
Zhang, Jiming
Xie, Qing
Wan, Mobin
Tang, Hong
Chen, Shijun
Gao, Zhiliang
Wang, Yuming
Zhang, Dazhi
Huang, Wenxiang
Sheng, Jifang
Ning, Qin
Yang, Dongliang
Lu, Jian
Pan, Chen
Yang, Yuxiu
Wang, Jue
Sun, Chuanzhen
Wang, Qixin
Hou, Jinlin
BMC GASTROENTEROLOGY, 2019, 19 (1)
[6] Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China
Jian Sun
Huiguo Ding
Guofeng Chen
Guiqiang Wang
Lai Wei
Jiming Zhang
Qing Xie
Mobin Wan
Hong Tang
Shijun Chen
Zhiliang Gao
Yuming Wang
Dazhi Zhang
Wenxiang Huang
Jifang Sheng
Qin Ning
Dongliang Yang
Jian Lu
Chen Pan
Yuxiu Yang
Jue Wang
Chuanzhen Sun
Qixin Wang
Jinlin Hou
BMC Gastroenterology, 19
[7] PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2B FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING ON-TREATMENT HBSAG DECLINE
Sonneveld, Milan J.
Rijckborst, Vincent
Boucher, Charles A.
Hansen, Bettina E.
Janssen, Harry L.
HEPATOLOGY, 2010, 52 (04) : 530A - 530A
[8] ON-TREATMENT HBSAG AND HBEAG LEVELS AS POTENTIAL PREDICTORS OF DURABLE OFF-TREATMENT HBEAG SEROCONVERSION FOR HBEAG-POSITIVE CHB PATIENTS TREATED WITH PEGINTERFERON ALFA-2B NOT CONVENTIONAL INTERFERON ALFA-2B
Ma, Hui
Yang, Ruifeng
Wei, Lai
HEPATOLOGY, 2009, 50 (04) : 527A - 527A
[9] ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
Lau, G. K. K.
Marcellin, P.
Brunetto, M.
Piratvisuth, T.
Kapprell, H. -P
Messinger, D.
Popescu, M.
JOURNAL OF HEPATOLOGY, 2009, 50 : S333 - S333
[10] LONG-TERM FOLLOW-UP OF PEGINTERFERON ALFA TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS IN PHASE III STUDY OF PEGINTERFERON ALFA-2b (40kD, Y SHAPE) (PEGBERON): A 4-YEAR FOLLOW-UP REPORT
Wang, Guiqiang
Hou, Fengqin
Zhang, Min
Shang, Jia
Pan, Chen
Lv, Hui
Zhang, Mingxiang
Peng, Yanzhong
Xie, Qing
Wang, Maorong
Zhang, Dazhi
Chen, Yongping
Mao, Qianguo
Liu, Jiajun
Peng, Jie
Mao, Qing
Yang, Yongfeng
Yin, Chibiao
Han, Tao
Cheng, Na
Zhen, Zhen
Zhang, Jiming
Tan, Deming
Chen, Liang
Meng, Qinghua
Wang, Hao
Chen, Chengwei
Li, Baosen
Chen, Jun
Yin, Yalin
Sun, Li
HEPATOLOGY, 2020, 72 : 488A - 489A

← 1 2 3 4 5 →